Previous 10 | Next 10 |
By Michelle Borré, CFA, Head of Fundamental Alternative Strategies , and Brian Giesen, CFA, Intermediate Research Analyst Restrictions on the pricing of drugs delivered in doctors' offices and hospitals could have significant investment implications. The Trump Administration is...
It's time to talk about a new venture called EQRx. This has made quite a splash in the last few days at the JPMorgan investor conference, and it's been launched by Alexis Borisy (involved with founding and/or helping run CombinatoRx, Foundation, Blueprint, WarpDrive Bio, Editas, Relay, and oth...
Ben Graham famously described Mr. Market's psychological state from day to day as vulnerable to erratic swings of optimism and pessimism. But recent history shows that the crowd has exhibited a mostly stable view on commodities and energy by consistently discounting these assets by relatively ...
Success is not final; failure is not fatal: it is the courage to continue that counts. - Winston Churchill Not all companies are scared of a drug losing patent protection. Generics are drugs identical in chemical composition to the original medicines, and hence, rely heavily on the e...
SPDR S&P Pharmaceuticals ETF (NYSEARCA: XPH ) - $0.0711 . More news on: SPDR S&P Pharmaceuticals ETF, Dividend News, News on ETFs, , Read more ...
Gainers: Direxion Daily Pharmaceutical & Medical Bull 3X (NYSEARCA: PILL ) +26.2% . More news on: Direxion Shares ETF Trust - Direxion Daily Pharmaceutical & Medical Bull 3X Shares, Direxion Daily Natural Gas Related Bull 3x Shares ETF, Direxion Daily S&P Oil &...
( Source ) Santa Claus may bring presents to all the good children of the world, but investors are anxious about the President and his trade war and trying to find their own holiday cheer this Christmas. Hopes for a "Phase One" deal may have helped the S&P 500 to new highs even as earnin...
Look to the nervous system as the key to maximum health. - Galen The US is the largest manufacturer and consumer of pharmaceuticals and spends the most on research & development. The most logical result follows. American companies are fetching the most revenues from around the worl...
Healthcare Pulse Healthcare is at its all-time highs eclipsing the highs recorded a year earlier during the Oct-Nov 2018 period. Of course, if one looks at the broader market which has been recording such all-time highs since the summer of this year, it's understandable to shrug shoulders ...
In a statement , the FDA says chronic shortages of certain medicines in the U.S. have not produced the expected responses from drugmakers that traditional economics predict, specifically, increasing prices to reflect a supply/demand imbalance aimed at achieving profitable production to sati...
News, Short Squeeze, Breakout and More Instantly...
SPDR S&P Pharmaceuticals Company Name:
XPH Stock Symbol:
NYSE Market:
Second Quarter 2024 Highlights: Record sales of $3.61 billion, up 18% in U.S. dollars and 11% organically compared to the second quarter of 2023 GAAP Diluted EPS of $0.41, up 11% compared to prior year Record Adjusted Diluted EPS of $0.44, up 22% compared to prior year ...
2024-07-19 12:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Transaction highlights: To acquire CommScope’s Outdoor Wireless Networks and Distributed Antenna Systems businesses for $2.1 billion in cash Adds advanced antenna and associated interconnect products, technologies and capabilities Complements Amphenol’s existing prod...